Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Immunostaining for galactose-deficient immunoglobulin A is not specific for primary immunoglobulin A nephropathy.

Cassol CA, Bott C, Nadasdy GM, Alberton V, Malvar A, Nagaraja HN, Nadasdy T, Rovin BH, Satoskar AA.

Nephrol Dial Transplant. 2019 Aug 1. pii: gfz152. doi: 10.1093/ndt/gfz152. [Epub ahead of print]

PMID:
31369128
2.

Staphylococcus Infection-Associated GN - Spectrum of IgA Staining and Prevalence of ANCA in a Single-Center Cohort.

Satoskar AA, Suleiman S, Ayoub I, Hemminger J, Parikh S, Brodsky SV, Bott C, Calomeni E, Nadasdy GM, Rovin B, Hebert L, Nadasdy T.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):39-49. doi: 10.2215/CJN.05070516. Epub 2016 Nov 7.

3.

Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.

Wada Y, Matsumoto K, Suzuki T, Saito T, Kanazawa N, Tachibana S, Iseri K, Sugiyama M, Iyoda M, Shibata T.

PLoS One. 2018 Nov 2;13(11):e0206865. doi: 10.1371/journal.pone.0206865. eCollection 2018.

4.

IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.

Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, Kano T, Suzuki Y.

Kidney Int. 2018 Mar;93(3):700-705. doi: 10.1016/j.kint.2017.10.019. Epub 2018 Jan 10.

5.

A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases.

Yanagawa H, Suzuki H, Suzuki Y, Kiryluk K, Gharavi AG, Matsuoka K, Makita Y, Julian BA, Novak J, Tomino Y.

PLoS One. 2014 May 23;9(5):e98081. doi: 10.1371/journal.pone.0098081. eCollection 2014.

6.

Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.

Rizk DV, Saha MK, Hall S, Novak L, Brown R, Huang ZQ, Fatima H, Julian BA, Novak J.

J Am Soc Nephrol. 2019 Oct;30(10):2017-2026. doi: 10.1681/ASN.2018111156. Epub 2019 Aug 23.

PMID:
31444275
7.

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?

Suzuki H, Allegri L, Suzuki Y, Hall S, Moldoveanu Z, Wyatt RJ, Novak J, Julian BA.

Dis Markers. 2016;2016:7806438. doi: 10.1155/2016/7806438. Epub 2016 Aug 28.

8.

Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy.

Eison TM, Hastings MC, Moldoveanu Z, Sanders JT, Gaber L, Walker PD, Lau KK, Julian BA, Novak J, Wyatt RJ.

Clin Nephrol. 2012 Dec;78(6):465-9. doi: 10.5414/CN107423.

9.

Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis.

Zhang X, Xie X, Shi S, Liu L, Lv J, Zhang H.

Nephrol Dial Transplant. 2019 Aug 3. pii: gfz151. doi: 10.1093/ndt/gfz151. [Epub ahead of print]

PMID:
31377786
10.

Post-transplant immunoglobulin A deposition and nephropathy in allografts.

Sofue T, Suzuki H, Ueda N, Kushida Y, Minamino T.

Nephrology (Carlton). 2018 Jul;23 Suppl 2:4-9. doi: 10.1111/nep.13281. Review.

PMID:
29968406
11.

Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.

Ebefors K, Liu P, Lassén E, Elvin J, Candemark E, Levan K, Haraldsson B, Nyström J.

BMC Nephrol. 2016 Apr 5;17:40. doi: 10.1186/s12882-016-0251-5.

12.

A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.

Dong J, Peng T, Gao J, Jia X, Yan G, Wang Y.

BMC Immunol. 2018 Jun 20;19(1):18. doi: 10.1186/s12865-018-0254-z.

13.

Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.

Yasutake J, Suzuki Y, Suzuki H, Hiura N, Yanagawa H, Makita Y, Kaneko E, Tomino Y.

Nephrol Dial Transplant. 2015 Aug;30(8):1315-21. doi: 10.1093/ndt/gfv221. Epub 2015 Jun 23.

14.

Serum galactose-deficient IgA1 levels in children with IgA nephropathy.

Jiang M, Jiang X, Rong L, Xu Y, Chen L, Qiu Z, Mo Y.

Int J Clin Exp Med. 2015 May 15;8(5):7861-6. eCollection 2015.

15.

The immunohistology of IgA nephropathy.

Jennette JC.

Am J Kidney Dis. 1988 Nov;12(5):348-52.

PMID:
3142256
16.

Paradigm shift in activity assessment of IgA nephropathy - optimizing the next generation of diagnostic and therapeutic maneuvers via glycan targeting.

Suzuki Y, Suzuki H, Yasutake J, Tomino Y.

Expert Opin Biol Ther. 2015 Apr;15(4):583-93. doi: 10.1517/14712598.2015.1006624. Epub 2015 Jan 20. Review.

PMID:
25604055
17.

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy.

Chen P, Shi SF, Qu Z, Zhao N, Xie XF, Lv JC, Liu LJ, Zhang H.

Ren Fail. 2018 Nov;40(1):213-218. doi: 10.1080/0886022X.2018.1455591.

18.

Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.

Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC.

Kidney Int. 2011 Dec;80(12):1352-63. doi: 10.1038/ki.2011.276. Epub 2011 Aug 24.

19.

Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.

Zhang K, Li Q, Zhang Y, Shang W, Wei L, Li H, Gao S, Yan T, Jia J, Liu Y, Lin S.

Kidney Blood Press Res. 2019 Oct 1:1-11. doi: 10.1159/000502579. [Epub ahead of print]

20.

Murine Models of Human IgA Nephropathy.

Suzuki H, Suzuki Y.

Semin Nephrol. 2018 Sep;38(5):513-520. doi: 10.1016/j.semnephrol.2018.05.021. Review.

PMID:
30177023

Supplemental Content

Support Center